Skip to main content

UnitedHealth Group income statement

  • UNH · NYSE
  • Insurance
  • Managed Health Care
  • S&P 500
$407.46+0.58%Close 13 Nov 2026

UnitedHealth Group reported revenue of $447.6 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 11.8% from fiscal 2024. Net income was $12.1 billion and diluted earnings per share $13.23.

From UnitedHealth Group's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

UnitedHealth Group income statement, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Revenue$75.43B$81.19B$87.14B$94.16B$101.9B$110.6B$122.5B$130.5B$157.1B$184.8B$201.2B$226.2B$242.2B$257.1B$287.6B$324.2B$371.6B$400.3B$447.6B$449.7B
Revenue growth—+7.6%+7.3%+8.1%+8.2%+8.6%+10.7%+6.5%+20.4%+17.7%+8.8%+12.5%+7.0%+6.2%+11.8%+12.7%+14.6%+7.7%+11.8%—
Selling, general and administrative$10.58B$13.10B$12.73B$14.27B$15.56B$17.31B$18.94B$21.26B$24.31B$28.40B$29.56B$34.07B$35.19B$41.70B$42.58B$47.78B$54.63B$53.01B$59.59B$61.02B
Operating income$7.85B$5.26B$6.36B$7.86B$8.46B$9.25B$9.62B$10.27B$11.02B$12.93B$15.21B$17.34B$19.68B$22.41B$23.97B$28.43B$32.36B$32.29B$18.96B$23.92B
Operating margin10.4%6.5%7.3%8.4%8.3%8.4%7.9%7.9%7.0%7.0%7.6%7.7%8.1%8.7%8.3%8.8%8.7%8.1%4.2%5.3%
Interest expense$544.0M$639.0M$551.0M$481.0M$505.0M$632.0M$708.0M$618.0M$790.0M$1.07B$1.19B$1.40B$1.70B$1.66B$1.66B$2.09B$3.25B$3.91B$4.00B$3.85B
Income before tax$7.30B$4.62B$5.81B$7.38B$7.96B$8.62B$8.91B$9.66B$10.23B$11.86B$14.02B$15.94B$17.98B$20.74B$22.31B$26.34B$29.11B$20.07B$14.70B$19.73B
Income tax expense$2.65B$1.65B$1.99B$2.75B$2.82B$3.10B$3.24B$4.04B$4.36B$4.79B$3.20B$3.56B$3.74B$4.97B$4.58B$5.70B$5.97B$4.83B$1.89B$3.07B
Effective tax rate36.3%35.6%34.2%37.2%35.4%35.9%36.4%41.8%42.6%40.4%22.8%22.3%20.8%24.0%20.5%21.7%20.5%24.1%12.9%15.5%
Net income$4.65B$2.98B$3.82B$4.63B$5.14B$5.53B$5.63B$5.62B$5.81B$7.02B$10.56B$11.99B$13.84B$15.40B$17.29B$20.12B$22.38B$14.40B$12.06B$15.88B
Net margin6.2%3.7%4.4%4.9%5.0%5.0%4.6%4.3%3.7%3.8%5.2%5.3%5.7%6.0%6.0%6.2%6.0%3.6%2.7%3.5%
EPS · diluted$3.42$2.40$3.24$4.10$4.73$5.28$5.50$5.70$6.01$7.25$10.72$12.19$14.33$16.03$18.08$21.18$23.86$15.51$13.23$17.52
Diluted weighted average shares1.4B1.2B1.2B1.1B1.1B1.0B1.0B986M967M968M985M983M966M961M956M950M938M929M911M906M
Basic weighted average shares1.3B1.2B1.2B1.1B1.1B1.0B1.0B972M953M952M964M963M951M949M943M937M928M921M908M904M
EBITDA$8.64B$6.24B$7.35B$8.93B$9.59B$10.56B$11.00B$11.75B$12.71B$14.98B$17.45B$19.77B$22.41B$25.30B$27.07B$31.84B$36.33B$36.39B$23.32B$28.18B
EBITDA margin11.5%7.7%8.4%9.5%9.4%9.5%9.0%9.0%8.1%8.1%8.7%8.7%9.3%9.8%9.4%9.8%9.8%9.1%5.2%6.3%
Depreciation & amortization$796.0M$981.0M$991.0M$1.06B$1.12B$1.31B$1.38B$1.48B$1.69B$2.06B$2.25B$2.43B$2.72B$2.89B$3.10B$3.40B$3.97B$4.10B$4.36B$4.26B
Stock-based compensation$505.0M$305.0M$334.0M$326.0M$401.0M$421.0M$331.0M$364.0M$406.0M$485.0M$597.0M$638.0M$697.0M$679.0M$800.0M$925.0M$1.06B$1.02B$971.0M$1.02B
Dividends per share$0.03$0.03$0.03$0.41$0.61$0.80$1.05$1.41$1.88$2.38$2.88$3.45$4.14$4.83$5.60$6.40$7.29$8.18$8.73$9.06

Quarterly

UnitedHealth Group income statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$94.43B$99.80B$98.86B$100.8B$100.8B$109.6B$111.6B$113.2B$113.2B$111.7B$112.0B$112.7B
Selling, general and administrative$13.34B$14.08B$13.16B$13.28B$12.49B$13.59B$13.78B$15.22B$17.00B$15.39B$14.27B$14.37B
Operating income$7.69B$7.93B$7.88B$8.71B$7.77B$9.12B$5.15B$4.32B$380.0M$8.99B$7.99B$6.56B
Operating margin8.1%7.9%8.0%8.6%7.7%8.3%4.6%3.8%0.3%8.0%7.1%5.8%
Interest expense$830.0M$844.0M$985.0M$1.07B$1.00B$998.0M$1.03B$1.00B$974.0M$955.0M$962.0M$963.0M
Income before tax$6.86B$1.00M$5.67B$7.61B$6.79B$8.11B$4.08B$3.23B−$720.0M$7.96B$6.97B$5.52B
Income tax expense$1.18B$1.22B$1.24B$1.36B$1.01B$1.63B$510.0M$686.0M−$938.0M$1.48B$1.30B$1.22B
Effective tax rate17.3%122200%22.0%17.8%14.8%20.1%12.5%21.2%130%18.6%18.6%22.2%
Net income$5.46B−$1.41B$4.22B$6.05B$5.54B$6.29B$3.41B$2.35B$10.00M$6.28B$5.48B$4.11B
Net margin5.8%−1.4%4.3%6.0%5.5%5.7%3.1%2.1%0.0%5.6%4.9%3.6%
EPS · diluted$5.85−$1.53$4.54$6.51$5.99$6.85$3.74$2.59$0.01$6.90$6.04$4.56
Diluted weighted average shares932M922M928M930M926M918M910M908M908M910M906M902M
Basic weighted average shares922M922M921M923M918M912M907M906M908M908M902M897M
EBITDA$8.66B$8.93B$8.89B$9.75B$8.81B$10.18B$6.23B$5.41B$1.50B$10.02B$9.03B$7.64B
EBITDA margin9.2%8.9%9.0%9.7%8.7%9.3%5.6%4.8%1.3%9.0%8.1%6.8%
Depreciation & amortization$974.0M$997.0M$1.02B$1.04B$1.04B$1.06B$1.08B$1.10B$1.12B$1.03B$1.04B$1.07B
Stock-based compensation$208.0M$372.0M$222.0M$237.0M$187.0M$375.0M$197.0M$223.0M$176.0M$348.0M$276.0M$219.0M
Dividends per share$1.88$1.88$2.10$2.10$2.10$2.10$2.21$2.21$2.21$2.21$2.32$2.32

The main figures as JSON and plain text. See data and methodology.

UNH in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.